Science is interesting and good. Potential is good. Progress is ok, but unfortunately the presentations did not meet my expectations and being in the medical sciences field i have realistic expectations. So, I opted out (disclosure changed accordingly) and will keep a close eye on this in the next 12 month. Having said that, if one is a loyal shareholder and are supporting the company for perhaps also personsl reasons that are beyond funancial insentive, then IMO it is a stock worth holding long term.
Ann: Alterity Presents New Data on ATH434, page-5
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.001(25.0%) |
Mkt cap ! $26.22M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $10.54K | 2.185M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 59 | 83226460 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 20397608 | 18 |
View Market Depth
| Last trade - 10.13am 07/06/2024 (20 minute delay) ? |
| ATH (ASX) Chart |